Stocks and Investing Stocks and Investing
Mon, December 6, 2021
Sat, December 4, 2021
Fri, December 3, 2021
Thu, December 2, 2021
Wed, December 1, 2021
Tue, November 30, 2021

Patrick Trucchio Maintained (VIR) at Strong Buy with Increased Target to $200 on, Nov 30th, 2021


Published on 2024-10-27 18:49:10 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Increased Target from $135 to $200 on, Nov 30th, 2021.

Patrick has made no other calls on VIR in the last 4 months.



There are 3 other peers that have a rating on VIR. Out of the 3 peers that are also analyzing VIR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $37 on, Monday, October 25th, 2021
  • Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Wednesday, September 22nd, 2021


This is the rating of the analyst that currently disagrees with Patrick


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021